Brief: Xintela Signs Contract With Australian CRO For Clinical Study
July 16 (Reuters) - Xintela AB XINT.ST :
* XINTELA SIGNS WITH AUSTRALIAN CRO FOR CLINICAL STUDY
* XINTELA ANNOUNCES TODAY THAT COMPANY HAS SIGNED A CONTRACT
WITH
GREENLIGHT CLINICAL
* PLANNED TO BE INITIATED IN Q4 2021
Source text for Eikon: ID:nBQN3lzfxf
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects